Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Niagen Bioscience Inc.
Swot
Niagen Bioscience Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Niagen Bioscience Inc. has 26 Strengths, 6 Weaknesses, 3 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(26)
Weakness
(6)
Opportunity
(3)
Threats
(0)
Others
(1)
High DVM Mid and Small Caps (subscription)
Expensive Stars (DVM)
Consistent Highest Return Stocks over Five Years
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over the Quarter (3 Months)
Weekly Strategy: High Momentum Score Stocks (subscription)
Annual Profit Growth higher than Sector Profit Growth
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock gained more than 20% in one month
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
PE higher than Industry PE
PEG greater than Industry PEG
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Top Losers
Top Losers
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
MFs increased their shareholding last quarter
Promoters increasing shareholding QoQ
